RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $904M
1-Year Est. Return 12.31%
This Quarter Est. Return
1 Year Est. Return
+12.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$870M
AUM Growth
-$103M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
104
New
Increased
Reduced
Closed

Top Buys

1
+$23M
2
+$19.8M
3
+$11.2M
4
MOH icon
Molina Healthcare
MOH
+$11.2M
5
DXCM icon
DexCom
DXCM
+$10.6M

Top Sells

1
+$21.9M
2
+$21.4M
3
+$16.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$14.7M
5
BSX icon
Boston Scientific
BSX
+$14.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$40.6M 4.66%
77,430
+16,900
2
$34.5M 3.96%
41,750
-3,700
3
$32.4M 3.72%
66,750
+16,750
4
$31.8M 3.65%
47,217
+13,100
5
$30.3M 3.48%
300,000
-144,000
6
$26.6M 3.05%
270,000
+233,469
7
$26.2M 3.01%
233,500
-22,000
8
$26.1M 3%
448,000
+27,655
9
$25.5M 2.93%
51,500
-12,500
10
$24.9M 2.86%
1,337,284
-423,908
11
$22.9M 2.63%
255,000
-14,500
12
$22.5M 2.58%
68,200
+34,000
13
$21.3M 2.45%
48,950
+25,800
14
$20.1M 2.31%
31,750
-11,707
15
$19.9M 2.29%
236,000
+121,000
16
$19.8M 2.28%
+325,000
17
$19.6M 2.25%
138,500
+15,090
18
$19M 2.19%
440,000
-31,000
19
$18.7M 2.15%
265,000
+14,377
20
$18.6M 2.13%
88,650
-35,500
21
$17M 1.96%
126,700
-71,000
22
$16M 1.84%
61,000
+4,000
23
$16M 1.84%
235,862
-31,638
24
$15.4M 1.77%
124,300
-21,200
25
$14.2M 1.63%
185,500
+124,000
1
2 3 4 5